Kuehn Law is investigating Fractyl Health for allegedly misleading shareholders about the effectiveness of its outpatient therapy, Revita. The lawsuit claims the company overstated Revita's clinical and commercial prospects and failed to disclose operational issues affecting study results. Shareholders who bought stock before January 13, 2025, are encouraged to contact the law firm to protect their rights. This case highlights potential risks in biotech investments tied to clinical trial transparency.
Fractyl Health, Inc. is the subject of a shareholder lawsuit concerning its outpatient therapy Revita. For readers following the health sector, here is Pluang's market snapshot as of Sep 24, 2026 03:02 WIB: out of 100 priced US health stocks, 37 rose and 63 fell. Notable movers include BNGO at USD 1.86 with a 7.51% increase and a typical hold time of 49 days, SANA at USD 3.09 down 7.21% with 93% buy order activity, and AMLX at USD 30.74 down 6.85% with a typical hold time of 14 days.
NeoVolta reported a weak Q4 with revenue dropping to $13,460 and a loss of $0.24 per share, missing analyst expectations. Despite this, full-year revenue rose 58% to $13.3 million as the company expanded beyond residential markets. The Q4 loss widene...
BlackBerry is expected to report Q3 earnings with an EPS of $0.04 and revenue around $143.55 million, in line with company guidance. The company has a strong track record of beating earnings estimates, driven by growth in its QNX automotive software ...
On September 23, Jaguar Health's stock plunged about 74%, reversing a prior gain, without any confirmed negative news. Alkami Technology's shares fell 19% after ending a strategic review and deciding to remain independent. Other stocks like Cullinan ...
Wheeler REIT (WHLR) surged 190.91% after a 1-for-9 reverse stock split, though no new catalyst was confirmed. Artelo Biosciences (ARTL) rose 74% following a provisional patent application for its obesity drug candidate ART27.13, based on early mouse ...
Costco Wholesale announced $93.9 billion in net sales for its fiscal Q4, up 11.3% from last year, with comparable sales rising 9.4%. The full earnings report on September 24 will reveal membership fees, total revenue, expenses, and profit details. An...
